12
Views
103
CrossRef citations to date
0
Altmetric
Research Article

Subunit Composition Determines E2F DNA-Binding Site Specificity

, , &
Pages 6994-7007 | Received 23 May 1997, Accepted 26 Aug 1997, Published online: 29 Mar 2023

References

  • Adnane, J., Z. Shao, and P. D. Robbins. 1995. The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J. Biol. Chem. 270:8837–8843.
  • Bagchi, S., P. Raychaudhuri, and J. R. Nevins. 1990. Adenovirus E1A can dissociate heteromeric complexes involving the E2F transcription factor: A novel mechanism for E1A trans-activation. Cell 62:659–669.
  • Bandara, L. R., V. M. Buck, M. Zamanian, L. H. Johnston, and N. B. La Thangue. 1993. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J. 12:4317–4324.
  • Bandara, L. R., and N. B. La Thangue. 1991. Adenovirus E1A prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature (London) 351:494–497.
  • Beijersbergen, R. L., R. M. Kerkhoven, L. Zhu, L. Carlee, P. M. Voorhoeve, and R. Bernards. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8:2680–2690.
  • Bennett, J. D., P. G. Farlie, and R. J. Watson. 1996. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts. Oncogene 13:1073–1082.
  • Blake, M. C., and J. C. Azizkhan. 1989. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol. 9:4994–5002.
  • Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097–1105.
  • Cao, L., B. Faha, M. Dembski, L.-H. Tsai, E. Harlow, and N. Dyson. 1992. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (London) 355:176–179.
  • Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the Rb protein. Cell 65:1053–1061.
  • Chen, P.-L., P. Scully, J.-Y. Shew, J. Y. J. Wang, and W.-H. Lee. 1989. Phosphorylation of the retinoblastoma gene product is modified during the cell cycle and cellular differentiation. Cell 58:1193–1198.
  • Chittenden, T., D. M. Livingston, and W. G. J. Kaelin. 1991. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 65:1073–1082.
  • Claudio, P. P., C. M. Howard, A. Baldi, A. De Luca, Y. Fu, G. Condorelli, Y. Sun, N. Colburn, B. Calabretta, and A. Giordano. 1994. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res. 54:5556–5560.
  • Cobrinik, D., P. Whyte, D. S. Peeper, T. Jacks, and R. A. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7:2392–2404.
  • Cress, W. D., and J. R. Nevins. 1994. Interacting domains of E2F1, DP1, and the adenovirus E4 protein. J. Virol. 68:4213–4219.
  • Cress, W. D., and J. R. Nevins. 1996. A role for a bent DNA structure in E2F-mediated transcription activation. Mol. Cell. Biol. 16:2119–2127.
  • DeCaprio, J. A., J. W. Ludlow, J. Figge, J.-Y. Shew, C.-M. Huang, W.-H. Lee, E. Marsilio, E. Paucha, and D. M. Livingston. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275–282.
  • DeGregori, J., T. Kowalik, and J. R. Nevins. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15:4215–4224.
  • Dyson, N., P. M. Howley, K. Munger, and E. Harlow. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934–937.
  • Field, S. J., F.-Y. Tsai, F. Kuo, A. M. Zubiaga, W. G. Kaelin, Jr., D. M. Livingston, S. H. Orkin, and M. E. Greenberg. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549–561.
  • Fry, C. J., J. E. Slansky, and P. J. Farnham. 1997. Position-dependent transcriptional regulation of the murine dihydrofolate reductase promoter by the E2F transactivation domain. Mol. Cell. Biol. 17:1966–1976.
  • Geng, Y., E. N. Eaton, M. Picon, J. M. Roberts, A. S. Lundberg, A. Gifford, C. Sardet, and R. A. Weinberg. 1996. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12:1173–1180.
  • Ginsberg, D., G. Vairo, T. Chittenden, Z.-X. Xiao, G. Xu, K. L. Wydner, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:2665–2679.
  • Helin, K., J. A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337–350.
  • Helin, K., C.-L. Wu, A. R. Fattaey, J. A. Lees, B. D. Dynlacht, C. Ngwu, and E. Harlow. 1993. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev. 7:1850–1861.
  • Hijmans, E. M., P. M. Voorhoeve, R. L. Beijersbergen, L. J. van’t Veer, and R. Bernards. 1995. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15:3082–3089.
  • Horowitz, J. M., and A. J. Udvadia. 1995. Regulation of transcription by the retinoblastoma (Rb) protein. Mol. Cell. Differ. 3:275–314.
  • Horowitz, J. M., D. W. Yandell, S.-H. Park, S. Canning, P. Whyte, K. J. Buchkovich, E. Harlow, R. A. Weinberg, and T. P. Dryja. 1989. Point mutational inactivation of the retinoblastoma antioncogene. Science 243:937–940.
  • Hsiao, K.-M., S. L. McMahon, and P. J. Farnham. 1994. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev. 8:1526–1537.
  • Hu, Q., N. Dyson, and E. Harlow. 1990. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J. 9:1147–1155.
  • Huber, H. E., P. J. Goodhart, and P. S. Huang. 1994. Retinoblastoma protein reverses DNA bending by transcription factor E2F. J. Biol. Chem. 269:6999–7005.
  • Johnson, D. G., K. Ohtani, and J. R. Nevins. 1994. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev. 8:1514–1525.
  • Kaelin, W. G., Jr., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, M. A. Blanar, D. M. Livingston, and E. K. Flemington. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351–364.
  • Karlseder, J., H. Rotheneder, and E. Wintersberger. 1996. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol. Cell. Biol. 16:1659–1667.
  • Kerppola, T. K., and T. Curran. 1991. DNA bending by Fos and Jun: the flexible hinge model. Science 254:1210–1214.
  • Kerppola, T. K., and T. Curran. 1991. Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations: implications for transcription factor cooperativity. Cell 66:317–326.
  • Kim, J., C. Zwieb, C. Wu, and S. Adhya. 1989. Bending of DNA by gene- regulatory proteins: construction and use of a DNA bending vector. Gene 85:15–23.
  • Kim, S.-J., U. S. Onwuta, Y. I. Lee, R. Li, M. R. Botchan, and P. D. Robbins. 1992. The retinoblastoma gene product regulates Sp1-mediated transcription. Mol. Cell. Biol. 12:2455–2463.
  • Knudson, A. G. J. 1993. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA 90:10914–10921.
  • Koo, H., H. Wu, and D. M. Crothers. 1986. DNA bending at adeninethymine tracts. Nature (London) 320:501–506.
  • Kovesdi, I., R. Reichel, and J. R. Nevins. 1986. Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45:219–228.
  • Krek, W., D. M. Livingston, and S. Shirodkar. 1993. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262:1557–1560.
  • Lam, E. W.-F., and N. B. La Thangue. 1995. DP and E2F proteins: coordinating transcription with cell cycle progression. Curr. Opin. Cell Biol. 6:859–866.
  • Lam, E. W.-F., and R. J. Watson. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12:2705–2713.
  • Lees, J. A., K. J. Buchkovich, D. R. Marshak, C. W. Anderson, and E. Harlow. 1991. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J. 10:4279–4290.
  • Lin, S.-Y., A. Rhys Black, D. Kostic, S. Pajovic, C. N. Hoover, and J. C. Azizkhan. 1996. Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol. Cell. Biol. 16:1668–1675.
  • Ludlow, J. W., J. Shon, J. M. Pipas, D. M. Livingston, and J. A. DeCaprio. 1990. The retinoblastoma susceptibility gene product undergoes cell cycledependent dephosphorylation and binding to and release from SV40 large T. Cell 60:387–396.
  • Magae, J., C.-L. Wu, S. Illenye, E. Harlow, and N. H. Heintz. 1996. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J. Cell. Sci. 109:1717–1726.
  • Mihara, K., X.-R. Cao, A. Yen, S. Chandler, B. Driscoli, A. L. Murphree, A. T’Ang, and Y.-K. T. Fung. 1989. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246:1300–1303.
  • Moberg, K., M. A. Starz, and J. A. Lees. 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16:1436–1449.
  • Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424–429.
  • Ohtani, K., J. DeGregori, G. Leone, D. R. Herendeen, T. J. Kelly, and J. R. Nevins. 1996. Expression of the HsOrc1 gene, a human ORC1 homolog, is regulated by cell proliferation via the E2F transcription factor. Mol. Cell. Biol. 16:6977–6984.
  • Ohtani, K., J. DeGregori, and J. R. Nevins. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92:12146–12150.
  • Ormondroyd, E., S. de la Luna, and N. B. La Thangue. 1995. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F. Oncogene 11:1437–1446.
  • Ouellette, M. M., J. Chen, W. E. Wright, and J. W. Shay. 1992. Complexes containing the retinoblastoma gene product recognize different DNA motifs related to the E2F binding site. Oncogene 7:1075–1081.
  • Reichel, R., I. Kovesdi, and J. R. Nevins. 1988. Activation of a preexisting cellular factor as a basis for adenovirus E1A-mediated transcription control. Proc. Natl. Acad. Sci. USA 85:387–390.
  • Rogers, K. T., P. D. R. Higgins, M. M. Milla, R. S. Phillips, and J. M. Horowitz. 1995. DP-2, a heterodimeric partner of E2F: identification and characterization of DP-2 proteins expressed in vivo. Proc. Natl. Acad. Sci. USA 93:7594–7599.
  • Schulze, A., K. Zerfass, D. Spitkovsky, S. Middendorp, J. Berges, K. Helin, P. Jansen-Durr, and B. Henglein. 1995. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl. Acad. Sci. USA 92:11264–11268.
  • Schwarz, J. K., S. H. Devoto, E. J. Smith, S. P. Chellappan, L. Jakoi, and J. R. Nevins. 1993. Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J. 12:1013–1020.
  • Sellers, W. R., J. W. Rodgers, and W. G. J. Kaelin. 1995. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA 92:11544–11548.
  • Shan, B., X. Zhu, P. Chen, T. Durfee, Y. Yang, D. Sharp, and W. Lee. 1992. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 12:5620–5631.
  • Shirodkar, S., M. Ewen, J. A. DeCaprio, J. Morgan, D. M. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and p107-cyclin A complex in a cell cycle-regulated manner. Cell 68:157–166.
  • Slansky, J. E., and P. J. Farnham. 1996. Introduction to the E2F family: protein structure and gene regulation, p. 1–30. In P. J. Farnham (ed.), Transcriptional control of cell growth: the E2F gene family. Springer-Verlag, New York, N.Y.
  • Sterner, J. M., Y. Murata, H. G. Kim, S. B. Kennett, D. J. Templeton, and J. M. Horowitz. 1995. Characterization of cellular proteins that form complexes with the amino-terminus of the retinoblastoma (Rb) protein: a novel cell-cycle regulated kinase associates with Rb in G2/M phases. J. Biol. Chem. 270:9281–9288.
  • Strauss, J. K., and L. J. I. Maher. 1994. DNA bending by asymmetric phosphate neutralization. Nature (London) 266:1829–1834.
  • Tao, Y., and J. M. Horowitz. Unpublished observations.
  • Taya, Y., H. Yasuda, M. Kamijo, K. Nakaya, Y. Nakamura, Y. Ohba, and S. Nishimura. 1989. In vitro phosphorylation of the tumor suppressor gene RB protein by mitosis-specific histone H1 kinase. Biochem. Biophys. Res. Commun. 164:580–586.
  • Thompson, J. F., and A. Landy. 1988. Empirical estimation of protein- induced DNA bending angles: application to lambda site-specific recombination complexes. Nucleic Acids Res. 16:9687–9705.
  • Tommasi, S., and G. P. Pfeifer. 1995. In vivo structure of the human cdc2 promoter: release of p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol. Cell. Biol. 15:6901–6913.
  • Udvadia, A. J., K. T. Rogers, P. D. R. Higgins, Y. Murata, K. H. Martin, P. A. Humphrey, and J. M. Horowitz. 1993. Sp-1 binds promoter elements regulated by the Rb protein and Sp-1-mediated transcription is stimulated by Rb co-expression. Proc. Natl. Acad. Sci. USA 90:3265–3269.
  • Vairo, G., D. M. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9:869–881.
  • Wade, M., M. C. Blake, R. C. Jambou, K. Helin, E. Harlow, and J. C. Azizkhan. 1995. An inverted repeat motif stabilizes binding of E2F and enhances transcription of the dihydrofolate reductase gene. J. Biol. Chem. 270:9783–9791.
  • Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
  • Weinberg, R. A. 1996. E2F and cell proliferation: a world turned upside down. Cell 85:457–459.
  • Weintraub, S. J., K. N. B. Chow, R. X. Luo, S. H. Zhang, S. He, and D. C. Dean. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature (London) 375:812–815.
  • Weintraub, S. J., C. A. Prater, and D. C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature (London) 358:259–261.
  • Wells, J., P. Held, S. Illenye, and N. H. Heintz. 1996. Protein-DNA interactions at the major and minor promoters of the divergently transcribed dhfr and rep3 genes during the Chinese hamster ovary cell cycle. Mol. Cell. Biol. 16:634–647.
  • Wells, J., S. Illenye, C.-L. Wu, and N. H. Heintz. 1997. Accumulation of E2F-4/DP-1 DNA binding complexes correlates with induction of dhfr gene expression during G1 to S phase transition. J. Biol. Chem. 272:4483–4492.
  • Whyte, P., K. J. Buchkovich, J. M. Horowitz, S. H. Friend, M. Raybuck, R. A. Weinberg, and E. Harlow. 1988. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma susceptibility gene product. Nature (London) 334:124–129.
  • Yamasaki, L., T. Jacks, R. Bronson, E. Goillot, E. Harlow, and N. J. Dyson. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85:537–548.
  • Yee, A. S., P. Raychaudhuri, L. Jakoi, and J. R. Nevins. 1989. The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding. Mol. Cell. Biol. 9:578–585.
  • Zamanian, M., and N. B. La Thangue. 1993. Transcriptional repression by the Rb-related protein p107. Mol. Biol. Cell 4:389–396.
  • Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. M. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111–1125.
  • Zhu, L., E. Xie, and L.-S. Chang. 1995. Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins. Mol. Cell. Biol. 15:3552–3562.
  • Zwicker, J., N. Liu, K. Engeland, F. C. Lucibello, and R. Muller. 1996. Cell cycle regulation of E2F site occupation in vivo. Science 271:1595–1597.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.